Overview
Consumers hardly noticed the first of two years’ worth of IRA-influenced changes on Part D plan designs and coverage costs. But now that’s changing. Monthly premium expenses that were once minor (or even non-existent) are now impacting seniors and their Social Security checks — and making them more prone to switching.
Our Medicare Part D Study reveals what the new drug cost reality will mean for MedSupp plus Part D, MAPD, and PDP as we look to 2026 and beyond. It also offers critical insights into how carriers might reduce possible attrition.
Insights from the 2024 Report
Adjusting for the Out-Of-Pocket Cap
In 2025, a new regulation under the Inflation Reduction Act (IRA) will implement a $2,000 annual out-of-pocket cap for Medicare Part D beneficiaries. To accommodate the financial implications of the cap, carriers may need to reevaluate their premium structures and plan designs. Discover how these changes could impact switching.